Mzf1 transcriptionally activated microrna-328-3p suppresses the malignancy of stomach adenocarcinoma via inhibiting cd44

HIGHLIGHTS

• who: MZF et al. from the Department, First Hospital of Medical University, Taiyuan, China have published the research work: MZF1 Transcriptionally Activated MicroRNA-328-3p Suppresses the Malignancy of Stomach Adenocarcinoma via Inhibiting CD44, in the Journal: Journal of Immunology Research of 28/05/2022
• what: In this experiment, the primer sequences were designed by Sangon Biotech Co . The authors intended to verify whether miR-328-3p could regulate biological processes of STAD in a CD44-dependent manner.
• how: The expression data of miR-328-3p was acquired from the downloaded raw data . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.